SLC5A2 and type 2 diabetes mellitus: As anticipated, inhibiting SGLT2 in our T2DM mouse model protected the renal tissue from these histopathological changes as shown by the decreased GSI, glomerular area, and expression levels of the markers of fibrosis, fibronectin, and collagen IV.